Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy of gevokizumab in reducing the risk of recurrent uveitic disease in subjects with non-infectious uveitis whose disease is currently controlled wit...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
XOMA (US) LLC
Collaborators
NCT07218770 · Active Noninfectious Uveitis Affecting the Posterior Segment
NCT06974162 · Uveitis, Aqueous Humor, and more
NCT07145008 · Macular Edema (ME), Non Infectious Uveitis
NCT05486468 · Uveitis, Uveitis, Posterior, and more
NCT05200715 · Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, and more
Chandler, Arizona
Phoenix, Arizona
Beverly Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions